ANNX

Annexon, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, focusing on revolutionary therapies for autoimmune and neurodegenerative diseases. Harnessing its proprietary technology platforms, the company is developing innovative treatments that aim to restore immune balance and enhance neuronal health. With a promising pipeline of drug candidates targeting significant unmet medical needs, Annexon is strategically positioned as a leading innovator within the biopharmaceutical sector. Its commitment to advancing groundbreaking therapies underscores its potential to make a substantial impact on patient care in the fields it serves.